TriSalus Life Sciences
(NASDAQ) TLSI
TriSalus Life Sciences Financials at a Glance
Market Cap
$164.60M
Revenue (TTM)
$44.88M
Net Income (TTM)
$27.31M
EPS (TTM)
$-1.41
P/E Ratio
-1.90
Dividend
$0.00
Beta (Volatility)
0.50 (Low)
Dividend
$0.00
Beta (Volatility)
0.50 (Low)
Price
$2.69
Volume
54,313
Open
$2.49
Price
$2.69
Volume
54,313
Open
$2.49
Previous Close
$2.69
Daily Range
$2.36 - $2.70
52-Week Range
$2.20 - $7.95
Dividend
$0.00
Beta (Volatility)
0.50 (Low)
Price
$2.69
Volume
54,313
Open
$2.49
Previous Close
$2.69
Daily Range
$2.36 - $2.70
52-Week Range
$2.20 - $7.95
TLSI News
TLSI: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout TriSalus Life Sciences
Industry
Biotechnology
Sector
Health CareEmployees
102
CEO
Mary T. Szela, MBA
Website
www.trisaluslifesci.comHeadquarters
Westminster, CO 80031, US
TLSI Financials
Key Financial Metrics (TTM)
Gross Margin
85%
Operating Margin
-62%
Net Income Margin
-61%
Return on Equity
0%
Return on Capital
-47%
Return on Assets
-38%
Earnings Yield
-52.63%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$164.60M
Shares Outstanding
61.42M
Volume
54.31K
Avg. Volume
339.97K
Financials (TTM)
Gross Profit
$38.19M
Operating Income
$26.95M
EBITDA
$26.95M
Operating Cash Flow
$18.01M
Capital Expenditure
$918.00K
Free Cash Flow
$18.93M
Cash & ST Invst.
$20.44M
Total Debt
$34.44M
TriSalus Life Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$8.90M
-2.9%
Gross Profit
$7.67M
-0.0%
Gross Margin
86.18%
N/A
Market Cap
$164.60M
N/A
Market Cap/Employee
$1.50M
N/A
Employees
110
N/A
Net Income
$1.54M
+114.8%
EBITDA
$8.28M
+7.9%
Quarterly Fundamentals
Net Cash
$22.07M
+209.7%
Accounts Receivable
$5.21M
-4.4%
Inventory
$3.78M
-9.2%
Long Term Debt
$34.27M
+3.9%
Short Term Debt
$218.00K
+84.7%
Return on Assets
-38.48%
N/A
Return on Invested Capital
-47.35%
N/A
Free Cash Flow
$6.62M
-26.0%
Operating Cash Flow
$6.48M
-44.0%